NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,043,666 | -16.9% | 136,580 | -8.6% | 0.00% | 0.0% |
| Q2 2023 | $7,269,123 | -1.5% | 149,386 | +12.4% | 0.00% | -33.3% |
| Q1 2023 | $7,380,553 | +32.4% | 132,935 | -4.2% | 0.00% | +50.0% |
| Q4 2022 | $5,574,390 | +1.3% | 138,770 | +10.5% | 0.00% | 0.0% |
| Q3 2022 | $5,503,000 | +8.0% | 125,590 | -12.6% | 0.00% | 0.0% |
| Q2 2022 | $5,094,000 | +2.7% | 143,747 | +17.9% | 0.00% | 0.0% |
| Q1 2022 | $4,959,000 | -52.1% | 121,890 | +9.9% | 0.00% | -33.3% |
| Q4 2021 | $10,362,000 | -3.8% | 110,946 | +14.7% | 0.00% | -25.0% |
| Q3 2021 | $10,776,000 | +12.1% | 96,697 | +14.2% | 0.00% | +33.3% |
| Q2 2021 | $9,610,000 | +50.3% | 84,640 | +34.5% | 0.00% | +50.0% |
| Q1 2021 | $6,392,000 | +1.3% | 62,940 | -0.7% | 0.00% | 0.0% |
| Q4 2020 | $6,307,000 | +65.5% | 63,375 | +20.1% | 0.00% | 0.0% |
| Q3 2020 | $3,812,000 | +35.0% | 52,770 | -6.8% | 0.00% | +100.0% |
| Q2 2020 | $2,824,000 | +109.2% | 56,635 | +26.8% | 0.00% | 0.0% |
| Q1 2020 | $1,350,000 | +16.7% | 44,680 | +30.1% | 0.00% | 0.0% |
| Q4 2019 | $1,157,000 | +14.4% | 34,332 | +11.4% | 0.00% | 0.0% |
| Q3 2019 | $1,011,000 | +201.8% | 30,823 | +154.2% | 0.00% | – |
| Q2 2019 | $335,000 | +163.8% | 12,125 | +96.1% | 0.00% | – |
| Q1 2019 | $127,000 | +56.8% | 6,183 | +6.1% | 0.00% | – |
| Q4 2018 | $81,000 | -33.6% | 5,826 | +14.5% | 0.00% | – |
| Q3 2018 | $122,000 | +20.8% | 5,090 | -4.7% | 0.00% | – |
| Q2 2018 | $101,000 | +83.6% | 5,340 | -10.3% | 0.00% | – |
| Q1 2018 | $55,000 | -25.7% | 5,950 | -27.7% | 0.00% | – |
| Q4 2017 | $74,000 | -32.1% | 8,235 | -2.7% | 0.00% | – |
| Q3 2017 | $109,000 | +19.8% | 8,460 | 0.0% | 0.00% | – |
| Q2 2017 | $91,000 | +37.9% | 8,460 | +14.2% | 0.00% | – |
| Q1 2017 | $66,000 | -24.1% | 7,411 | -0.7% | 0.00% | – |
| Q4 2016 | $87,000 | +117.5% | 7,464 | +96.9% | 0.00% | – |
| Q3 2016 | $40,000 | -59.6% | 3,790 | -54.2% | 0.00% | – |
| Q2 2016 | $99,000 | – | 8,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |